{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:14:09Z","timestamp":1793369649829,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jhep.2021.05.022","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T11:35:56Z","timestamp":1622460956000},"page":"795-809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":249,"title":["Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019"],"prefix":"10.1016","volume":"75","author":[{"given":"Pegah","family":"Golabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"AlQahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.05.022_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global\u00a0epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/17474124.2016.1099433","article-title":"Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis","volume":"10","author":"Golabi","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased\u00a0risk\u00a0of mortality by fibrosis stage in nonalcoholic fatty\u00a0liver\u00a0disease:\u00a0systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s12072-019-09995-8","article-title":"Hepatocellular carcinoma and non-alcoholic fatty liver disease","volume":"13","author":"Golabi","year":"2019","journal-title":"Hepatol Int [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep4.1599","article-title":"The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007-2017","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol Commun [Internet]"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2021.05.022_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","article-title":"Prevalence, gender, ethnic variations, and prognosis of NASH","volume":"46","author":"Hashimoto","year":"2011","journal-title":"J\u00a0Gastroentero [Internet]l"},{"key":"10.1016\/j.jhep.2021.05.022_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib12","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.3748\/wjg.v26.i25.3528","article-title":"Management of nonalcoholic fatty liver disease in the Middle East","volume":"26","author":"Sanai","year":"2020","journal-title":"World J Gastroenterol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.14740\/gr913w","article-title":"Non-alcoholic fatty liver disease in Africa and Middle East: an attempt to predict the present and future implications on the healthcare system","volume":"10","author":"Ahmed","year":"2017","journal-title":"Gastroenterol Res Pract [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(19)30179-2","article-title":"Metabolic health in the Middle East and north Africa","volume":"7","author":"Azizi","year":"2019","journal-title":"Lancet Diabetes Endocrinol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J\u00a0Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib17","series-title":"Global burden of disease study 2019 (GBD 2019) results","year":"2020"},{"key":"10.1016\/j.jhep.2021.05.022_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of nonalcoholic fatty liver disease","author":"Paik","year":"2020","journal-title":"Hepatology [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib20","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib21","series-title":"The power of models","year":"2018"},{"key":"10.1016\/j.jhep.2021.05.022_bib22","series-title":"An integrative metaregression framework for descriptive epidemiology","year":"2015"},{"key":"10.1016\/j.jhep.2021.05.022_bib23","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","year":"2018","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib24","unstructured":"University of Washington Institute of Health Metrics and Evaluation - GBD compare visualization Hub [Internet]. [cited 2019 Jun 27];Available from: https:\/\/vizhub.healthdata.org\/gbd-compare\/."},{"key":"10.1016\/j.jhep.2021.05.022_bib25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jhep.2018.06.025","article-title":"Predicting the future burden of NAFLD and NASH","volume":"69","author":"Mahady","year":"2018","journal-title":"J\u00a0Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy,\u00a0Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J\u00a0Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia [Internet]","volume":"67","author":"Fan","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.05.022_bib29","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2174\/1389557516666160505115512","article-title":"Dynamics of diabetes and obesity: an alarming situation in the developing countries in Asia","volume":"16","author":"Chakraborty","year":"2016","journal-title":"Mini Rev Med\u00a0Chem [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0971-5916.164234","article-title":"Prevalence of generalized & abdominal obesity in urban & rural India- the ICMR\u00a0- INDIAB Study (Phase-I) [ICMR - INDIAB-3] [Internet]","volume":"142","author":"Mohan","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jhep.2021.05.022_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the asia-pacific region: a lancet gastroenterology & hepatology commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019-2030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharmacol Ther [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib34","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology [Internet]"},{"issue":"Suppl","key":"10.1016\/j.jhep.2021.05.022_bib35","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3177\/jnsv.61.S17","article-title":"Monitoring obesity trends in health Japan 21","volume":"61","author":"Nishi","year":"2015","journal-title":"J\u00a0Nutr Sci Vitaminol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.15171\/mejdd.2019.147","article-title":"Burden of liver diseases: a review from Iran","volume":"11","author":"Anushiravani","year":"2019","journal-title":"Middle East J Dig Dis [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.5152\/tjg.2019.18045","article-title":"Non-alcoholic fatty liver disease: a growing public health problem in Turkey","volume":"30","author":"Kaya","year":"2019","journal-title":"Turk J Gastroenterol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden--Saudi Arabia and United Arab Emirates, 2017--2030","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J Gastroenterol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib39","article-title":"The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease","volume":"6","author":"Iqbal","year":"2019","journal-title":"Medicines (Basel) [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib40","first-page":"567","article-title":"Prevalence of overweight and obesity among adolescents in eight Arab countries: comparison between two international standards (ARABEAT-2)","volume":"33","author":"Musaiger","year":"2016","journal-title":"Nutr Hosp [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/tri.12694","article-title":"Liver transplantation for nonalcoholic steatohepatitis in young patients","volume":"29","author":"Alkhouri","year":"2016","journal-title":"Transpl Int [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOT.0000000000000502","article-title":"Nonalcoholic steatohepatitis: the new frontier for liver transplantation","volume":"23","author":"Bzowej","year":"2018","journal-title":"Curr Opin Organ Transpl [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis [Internet]","volume":"71","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.05.022_bib44","article-title":"Non-alcoholic fatty liver disease-A global public health perspective","author":"Younossi","year":"2018","journal-title":"J\u00a0Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.25003","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"24","author":"Younossi","year":"2018","journal-title":"Liver Transpl [Internet]"},{"key":"10.1016\/j.jhep.2021.05.022_bib46","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1016\/S0168-8278(20)31361-1","article-title":"Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians [Internet]","volume":"73","author":"Younossi","year":"2020","journal-title":"J\u00a0Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821003585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821003585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:44:26Z","timestamp":1759175066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821003585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0168827821003585"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.05.022","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}